flumazenil has been researched along with Fra(X) Syndrome in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Hulst, C | 1 |
Heulens, I | 1 |
Van der Aa, N | 1 |
Goffin, K | 1 |
Koole, M | 1 |
Porke, K | 1 |
Van De Velde, M | 1 |
Rooms, L | 1 |
Van Paesschen, W | 1 |
Van Esch, H | 1 |
Van Laere, K | 1 |
Kooy, RF | 1 |
1 trial available for flumazenil and Fra(X) Syndrome
Article | Year |
---|---|
Positron Emission Tomography (PET) Quantification of GABAA Receptors in the Brain of Fragile X Patients.
Topics: Adolescent; Adult; Animals; Brain; Female; Flumazenil; Fragile X Syndrome; Humans; Male; Mice; Middl | 2015 |